Posthoc analysis demonstrated that hydroxyproline levels in the high-dose HSP group were significantly lower than those in the control, gelatin sponge, and low-dose HSP groups (all p < 0.001, Table 4). The gene discussed is HSP90B2P; the disease is hereditary spastic paraplegia.